Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × CPG-oligonucleotide × Clear all

NCT00640861 2018-10-31

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms